Evidence map›Paper›PMID 33837874›Full record

ReviewBiogerontology2021

Lipids: biomarkers of healthy aging.

I Almeida, S Magalhães, A Nunes

Abstract readReview
PubMed Publisher
In one paragraph

Review in Biogerontology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Metabolomics to Study Human Aging: A Review.Current molecular medicine · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. The lipidomes ofAging · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

I AlmeidaDepartment of Medical Sciences, iBiMED - Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID 0000-0002-0639-0666
S MagalhãesDepartment of Medical Sciences, iBiMED - Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID 0000-0001-6850-0907
A NunesDepartment of Medical Sciences, iBiMED - Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal. alexandranunes@ua.pt.ORCID 0000-0002-0595-5821
University of Aveiro · PT

Funding

Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa (PT) SFRH/BD/131820/2017Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa (PT) UID/BIM/04501/2013 and P2020-PTDC/DTP-PIC/5587/2014Integrated Programme of SR&TD "pAGE" CENTRO-01-0145-FEDER-000003PIDDAC and by European Regional Development Fund (FEDER), POCI-01-0145-FEDER007628
6 · The paper itself

Abstract

Life expectancy, and longevity have been increasing in recent years. However, this is, in most cases, accompanied by age-related diseases. Thus, it became essential to better understand the mechanisms inherent to aging, and to establish biomarkers that characterize this physiological process. Among all biomolecules, lipids appear to be a good target for the study of these biomarkers. In fact, some lipids have already been associated with age-related diseases. With the development of analytical techniques such as Mass Spectrometry, and Nuclear Magnetic Resonance, Lipidomics has been increasingly used to study pathological, and physiological states of an organism. Thus, the study of serum, and plasma lipidome in centenarians, and elderly individuals without age-related diseases can be a useful tool for the identification of aging biomarkers, and to understand physiological aging, and longevity. This review focus on the importance of lipids as biomarkers of aging, and summarize the changes in the lipidome that have been associated with aging, and longevity.

Indexed as

Healthy AgingAgedAged, 80 and overAgingBiomarkersHumansLipidsLongevityBiomarkersLipidsAgingBiomarkers of agingLipidomicsLipidsLongevity

Identifiers

PMID33837874
OpenAlexW3145963016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.